Atherosclerotic renal artery stenosis: Current status

Soon Hyo Kwon, Lilach O Lerman

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Atherosclerotic renal artery stenosis (ARAS) remains a major cause of secondary hypertension and kidney failure. Randomized prospective trials show that medical treatment should constitute the main therapeutic approach in ARAS. Regardless of intensive treatment and adequate blood pressure control, however, renal and extrarenal complications are not uncommon. Yet, the precise mechanisms, accurate detection, and optimal treatment in ARAS remain elusive. Strategies oriented to early detection and targeting these pathogenic pathways might prevent development of clinical end points. Here, we review the results of recent clinical trials, current understanding of the pathogenic mechanisms, novel imaging techniques to assess kidney damage in ARAS, and treatment options.

Original languageEnglish (US)
Pages (from-to)224-231
Number of pages8
JournalAdvances in Chronic Kidney Disease
Volume22
Issue number3
DOIs
StatePublished - May 1 2015

Fingerprint

Renal Artery Obstruction
Kidney
Renal Insufficiency
Clinical Trials
Blood Pressure
Hypertension
Therapeutics

Keywords

  • Atherosclerosis
  • Hypertension
  • Inflammation
  • Ischemia
  • Renal artery obstruction

ASJC Scopus subject areas

  • Nephrology

Cite this

Atherosclerotic renal artery stenosis : Current status. / Kwon, Soon Hyo; Lerman, Lilach O.

In: Advances in Chronic Kidney Disease, Vol. 22, No. 3, 01.05.2015, p. 224-231.

Research output: Contribution to journalArticle

@article{d4d9d7b61ea44a67986ca8bd0d7f0636,
title = "Atherosclerotic renal artery stenosis: Current status",
abstract = "Atherosclerotic renal artery stenosis (ARAS) remains a major cause of secondary hypertension and kidney failure. Randomized prospective trials show that medical treatment should constitute the main therapeutic approach in ARAS. Regardless of intensive treatment and adequate blood pressure control, however, renal and extrarenal complications are not uncommon. Yet, the precise mechanisms, accurate detection, and optimal treatment in ARAS remain elusive. Strategies oriented to early detection and targeting these pathogenic pathways might prevent development of clinical end points. Here, we review the results of recent clinical trials, current understanding of the pathogenic mechanisms, novel imaging techniques to assess kidney damage in ARAS, and treatment options.",
keywords = "Atherosclerosis, Hypertension, Inflammation, Ischemia, Renal artery obstruction",
author = "Kwon, {Soon Hyo} and Lerman, {Lilach O}",
year = "2015",
month = "5",
day = "1",
doi = "10.1053/j.ackd.2014.10.004",
language = "English (US)",
volume = "22",
pages = "224--231",
journal = "Advances in Chronic Kidney Disease",
issn = "1548-5595",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Atherosclerotic renal artery stenosis

T2 - Current status

AU - Kwon, Soon Hyo

AU - Lerman, Lilach O

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Atherosclerotic renal artery stenosis (ARAS) remains a major cause of secondary hypertension and kidney failure. Randomized prospective trials show that medical treatment should constitute the main therapeutic approach in ARAS. Regardless of intensive treatment and adequate blood pressure control, however, renal and extrarenal complications are not uncommon. Yet, the precise mechanisms, accurate detection, and optimal treatment in ARAS remain elusive. Strategies oriented to early detection and targeting these pathogenic pathways might prevent development of clinical end points. Here, we review the results of recent clinical trials, current understanding of the pathogenic mechanisms, novel imaging techniques to assess kidney damage in ARAS, and treatment options.

AB - Atherosclerotic renal artery stenosis (ARAS) remains a major cause of secondary hypertension and kidney failure. Randomized prospective trials show that medical treatment should constitute the main therapeutic approach in ARAS. Regardless of intensive treatment and adequate blood pressure control, however, renal and extrarenal complications are not uncommon. Yet, the precise mechanisms, accurate detection, and optimal treatment in ARAS remain elusive. Strategies oriented to early detection and targeting these pathogenic pathways might prevent development of clinical end points. Here, we review the results of recent clinical trials, current understanding of the pathogenic mechanisms, novel imaging techniques to assess kidney damage in ARAS, and treatment options.

KW - Atherosclerosis

KW - Hypertension

KW - Inflammation

KW - Ischemia

KW - Renal artery obstruction

UR - http://www.scopus.com/inward/record.url?scp=84928017980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928017980&partnerID=8YFLogxK

U2 - 10.1053/j.ackd.2014.10.004

DO - 10.1053/j.ackd.2014.10.004

M3 - Article

C2 - 25908472

AN - SCOPUS:84928017980

VL - 22

SP - 224

EP - 231

JO - Advances in Chronic Kidney Disease

JF - Advances in Chronic Kidney Disease

SN - 1548-5595

IS - 3

ER -